ストックスクリーナーアプリを入手
4.65
2.42%
0.11
前日終値:
$4.54
開ける：
$4.55
24時間の取引高:
15,178
Relative Volume:
0.02
時価総額：
$318.16M
収益：
-
当期純損益:
$-96.66M
株価収益率:
-2.1628
EPS:
-2.15
ネットキャッシュフロー:
$-83.73M
1週間 パフォーマンス:
+1.97%
1か月 パフォーマンス:
+10.98%
6か月 パフォーマンス:
-20.51%
1年 パフォーマンス:
-69.39%
1日の値動き範囲:
$4.48
$4.76
1週間の範囲:
$4.37
$4.76
52週間の値動き範囲:
$2.86
$16.62
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
名前
Olema Pharmaceuticals Inc
セクター
電話
(415) 651-3316
住所
780 BRANNAN STREET, SAN FRANCISCO
OLMA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
4.65 | 314.05M | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.50 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.04 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.92 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
569.93 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.32 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-04-02 | 開始されました | Goldman | Buy |
| 2024-01-30 | 開始されました | Citigroup | Buy |
| 2023-07-21 | 開始されました | Oppenheimer | Outperform |
| 2023-05-05 | 開始されました | CapitalOne | Overweight |
| 2023-02-22 | 開始されました | Credit Suisse | Outperform |
| 2022-07-06 | 再開されました | Canaccord Genuity | Buy |
| 2022-06-09 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | 開始されました | H.C. Wainwright | Neutral |
| 2021-12-07 | 再開されました | Cowen | Outperform |
| 2020-12-14 | 開始されました | Canaccord Genuity | Buy |
| 2020-12-14 | 開始されました | Cowen | Outperform |
| 2020-12-14 | 開始されました | JP Morgan | Overweight |
| 2020-12-14 | 開始されました | Jefferies | Buy |
すべてを表示
Olema Pharmaceuticals Inc (OLMA) 最新ニュース
Is Olema Pharmaceuticals Inc. a good long term investmentConsistent high-performance stocks - Autocar Professional
Olema Pharmaceuticals Inc. Stock Analysis and ForecastBreakthrough capital growth - Autocar Professional
What analysts say about Olema Pharmaceuticals Inc. stockRemarkable growth - jammulinksnews.com
What drives Olema Pharmaceuticals Inc. stock priceConsistently high yield - jammulinksnews.com
What makes Olema Pharmaceuticals Inc. stock price move sharplyDaily Top Gainers - Newser
Why Olema Pharmaceuticals Inc. stock attracts strong analyst attentionFree Access to Group - Newser
How Olema Pharmaceuticals Inc. stock performs during market volatilityFree Top Growth Stock Recommendations - Newser
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Olema Oncology Awards $675K Worth of Stock Options to Key New Hires in Breast Cancer Research - Stock Titan
Deeper Dive: Understanding Olema Pharmaceuticals Inc (OLMA) Through its Various Ratios - DWinneX
Olema Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Two Sigma Investments LP Has $425,000 Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Squarepoint Ops LLC Grows Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
HC Wainwright Issues Pessimistic Outlook for OLMA Earnings - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Acquired by Wellington Management Group LLP - MarketBeat
Jane Street Group LLC Trims Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Q2 EPS Forecast for Olema Pharmaceuticals Lowered by Analyst - Defense World
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by Two Sigma Advisers LP - Defense World
ProShare Advisors LLC Purchases 3,298 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Ru - GuruFocus
Olema Pharmaceuticals Inc (OLMA) 財務データ
収益
当期純利益
現金流量
EPS
Olema Pharmaceuticals Inc (OLMA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Graham G. Walmsley | Director |
Dec 17 '24 |
Sale |
6.75 |
700,761 |
4,730,137 |
0 |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER |
Dec 16 '24 |
Option Exercise |
4.87 |
14,000 |
68,180 |
129,509 |
4.56%
0.55%
大文字化:
|
ボリューム (24 時間):